795PDGenomic profiling of circulating tumour DNA (ctDNA) and tumour tissue for the evaluation of rucaparib in metastatic castration-resistant prostate cancer (mCRPC). (23rd October 2018) - Chowdhury, S; McDermott, R; Piulats, J M; Shapiro, J D; Mejlholm, I; Morris, D; Ostler, P; Hussain, A; Dumbadze, I; Goldfischer, E R; Pintus, E; Benjelloun, A; et al.